Lv1
38 积分 2025-02-21 加入
144P Real-world risk of recurrence (ROR) and health care resource utilization (HCRU) in patients (pts) with HR+/HER2− early breast cancer (EBC) from a UK cancer registry
14小时前
求助中
Microbial modulation as a game changer: Boosting immunotherapy efficacy in breast cancer
1天前
已完结
Immunotherapy addition to neoadjuvant chemotherapy for early triple negative breast cancer: A systematic review and meta-analysis of randomized clinical trials
2天前
已完结
Addition of immune checkpoint inhibitors to chemotherapy versus chemotherapy alone in first-line metastatic triple-negative breast cancer: A systematic review and meta-analysis
2天前
已完结
皖公网安备34019202002308
